title: The appropriateness of nicotinic acid derivative use in patients with the metabolic syndrome: insights from the ARBITER 2 study.
authors.forename: Moutasim Homod
authors.initials: MH
authors.lastname: Al-Shaer
authors.forename: William P
authors.initials: WP
authors.lastname: Jerome
mesh_terms: D050171:Dyslipidemias / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000097:blood; D008055:Lipids / Q000097:blood; D024821:Metabolic Syndrome / Q000097:blood / Q000150:complications*; D009525:Niacin / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors
chemical_list: D000960:Hypolipidemic Agents; D007328:Insulin; D008055:Lipids; D009525:Niacin